drugset / Trial / NCT02382419
Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
Phase 2
Withdrawn
Rutgers, The State University of New Jersey
National Cancer Institute (NCI) · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This randomized phase II trial studies how well carrageenan-containing gel (vaginal gel) works in reducing the rate of human papilloma virus (HPV) infection in healthy participants. Carrageenans, which are naturally derived from seaweed, are enhancements to natural lubrication and may be effective in blocking HPV infection.
Timeline
- Start
- 2016-02-24
- Primary completion
- 2019-02-13
- Completion
- 2019-02-13
Outcome
Outcome not reported
Stopped (Enrollment): “Principal Investigator Decided to stop recruitment in the trial.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | carrageenan-containing gel | Unknown | — | Other |